Literature DB >> 32343505

Covid-19 - A Reminder to Reason.

Ivry Zagury-Orly1, Richard M Schwartzstein1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32343505     DOI: 10.1056/NEJMp2009405

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  23 in total

1.  Guidelines for the pharmacological treatment of COVID-19. The task-force/consensus guideline of the Brazilian Association of Intensive Care Medicine, the Brazilian Society of Infectious Diseases and the Brazilian Society of Pulmonology and Tisiology.

Authors:  Maicon Falavigna; Verônica Colpani; Cinara Stein; Luciano Cesar Pontes Azevedo; Angela Maria Bagattini; Gabriela Vilela de Brito; José Miguel Chatkin; Sergio Cimerman; Mirian de Freitas Dal Ben Corradi; Clovis Arns da Cunha; Flávia Cordeiro de Medeiros; Haliton Alves de Oliveira Junior; Leandro Genehr Fritscher; Marcelo Basso Gazzana; Débora Dalmas Gräf; Lays Pires Marra; Jessica Yumi Matuoka; Michelle Silva Nunes; Daniela Vianna Pachito; Cássia Garcia Moraes Pagano; Patrícia do Carmo Silva Parreira; Rachel Riera; Amilton Silva; Bruno de Melo Tavares; Alexandre Prehn Zavascki; Regis Goulart Rosa; Felipe Dal-Pizzol
Journal:  Rev Bras Ter Intensiva       Date:  2020-07-13

2.  Scientific quality of COVID-19 and SARS CoV-2 publications in the highest impact medical journals during the early phase of the pandemic: A case control study.

Authors:  Marko Zdravkovic; Joana Berger-Estilita; Bogdan Zdravkovic; David Berger
Journal:  PLoS One       Date:  2020-11-05       Impact factor: 3.240

3.  Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP).

Authors:  Matteo Bassetti; Daniele Roberto Giacobbe; Paolo Bruzzi; Emanuela Barisione; Stefano Centanni; Nadia Castaldo; Silvia Corcione; Francesco Giuseppe De Rosa; Fabiano Di Marco; Andrea Gori; Andrea Gramegna; Guido Granata; Angelo Gratarola; Alberto Enrico Maraolo; Malgorzata Mikulska; Andrea Lombardi; Federico Pea; Nicola Petrosillo; Dejan Radovanovic; Pierachille Santus; Alessio Signori; Emanuela Sozio; Elena Tagliabue; Carlo Tascini; Carlo Vancheri; Antonio Vena; Pierluigi Viale; Francesco Blasi
Journal:  Infect Dis Ther       Date:  2021-07-30

4.  Patient Harm During COVID-19 Pandemic: Using a Human Factors Lens to Promote Patient and Workforce Safety.

Authors:  M Abdulhadi Alagha; Francois Jaulin; Wesley Yeung; Leo Anthony Celi; Christopher V Cosgriff; Laura C Myers
Journal:  J Patient Saf       Date:  2021-03-01       Impact factor: 2.243

5.  Ideas and the origin of evidence during the COVID-19 pandemic.

Authors:  Mike Wells
Journal:  Emerg Med J       Date:  2020-06-17       Impact factor: 2.740

6.  MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy.

Authors:  Guido Moll; Norman Drzeniek; Julian Kamhieh-Milz; Sven Geissler; Hans-Dieter Volk; Petra Reinke
Journal:  Front Immunol       Date:  2020-05-19       Impact factor: 7.561

7.  Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019: CHEST Guideline and Expert Panel Report.

Authors:  Lisa K Moores; Tobias Tritschler; Shari Brosnahan; Marc Carrier; Jacob F Collen; Kevin Doerschug; Aaron B Holley; David Jimenez; Gregoire Le Gal; Parth Rali; Philip Wells
Journal:  Chest       Date:  2020-06-02       Impact factor: 9.410

8.  In defence of extrapolation but not improvisation in SARS-CoV-2 lung disease.

Authors:  Oleg Epelbaum; Irene Galperin
Journal:  Breathe (Sheff)       Date:  2020-06

9.  Dementia in the COVID-19 Period.

Authors:  Amos D Korczyn
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 10.  Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications.

Authors:  Joan T Merrill; Doruk Erkan; Jerald Winakur; Judith A James
Journal:  Nat Rev Rheumatol       Date:  2020-07-30       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.